Mutation Detection in the Menkes Gene ATP7A Using the Protein Truncation Test
2008

Detecting Mutations in the Menkes Gene Using a New Test

Sample size: 11 publication Evidence: moderate

Author Information

Author(s): Lisbeth Birk Møller, Nina Horn

Primary Institution: Kennedy Center

Hypothesis

Can the protein truncation test (PTT) effectively detect mutations in the ATP7A gene associated with Menkes disease?

Conclusion

The protein truncation test is a useful technique for rapidly detecting mutations in the N-terminal part of the ATP7A gene.

Supporting Evidence

  • The protein truncation test identified truncated products in all 11 patients.
  • No missense mutations were found in the critical region of the ATP7A gene.
  • The test is able to analyze multiple exons simultaneously.

Takeaway

Scientists created a test to quickly find problems in a gene that causes a rare disease, and it worked well for all the patients they checked.

Methodology

The study used a protein truncation test to analyze RNA from 11 patients with known mutations in the ATP7A gene.

Potential Biases

There is a risk of false negatives due to nonsense mediated decay in autosomal inherited disorders, but this is not a concern for X-linked disorders like Menkes disease.

Limitations

The test may not detect mutations located near the extreme ends of the protein product.

Participant Demographics

The study involved 11 patients diagnosed with Menkes disease and 3 normal controls.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication